Diabetes Mellitus: all 11,089 studies
Page 105 of 111. Open to participants first (1,319), then studies with results posted, then the rest; newest registration first within each.
- An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)TerminatedNCT00430742Phase 3
- Diabetes Genome Project: A Prospective Registry to Identify Genetic Variation Among Diabetic PatientsCompletedNCT00428961
- Laparoscopic Bariatric Surgery to Treat Type 2 Diabetes in Obese PatientsTerminatedNCT00428571Not applicable
- A Study To Evaluate PF-00915275 In Subjects With Type 2 Diabetes Mellitus For 4-WeeksTerminatedNCT00427401Phase 2
- Aspirin and Enalapril in Microalbuminuric Type 2 Diabetes Mellitus PatientsStatus unknownNCT00427271Phase 4
- Effect of Inhaled Pre-prandial Human Insulin on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00427154Phase 3
- Investigating the Pharmacokinetics and Pharmacodynamics of Recombinant Human Insulin Administered by Dry Powder InhalerStatus unknownNCT00426920Phase 1
- Ketosis Prone Diabetes in African-AmericansCompletedNCT00426413
- Study Evaluating PPM-204 In Subjects With Type 2 DiabetesTerminatedNCT00425919Phase 2
- Effect of Januvia on Beta Cell Function in Patients With Diabetes MellitusCompletedNCT00425490Phase 3
- FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis UlcersCompletedNCT00425178Phase 1
- Therapeutic Effects of Berberine in Patients With Type 2 DiabetesCompletedNCT00425009Phase 1/2
- Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.CompletedNCT00424437Phase 3
- Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 2 DiabetesCompletedNCT00424411Phase 3
- Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 DiabetesCompletedNCT00424333Phase 3
- A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.CompletedNCT00423501Phase 2
- LAPAS Study: Insulin Glargine in Type 2 Diabetes MellitusCompletedNCT00423215
- Safety and Tolerability Study of MBX-2044 in Patients With Type 2 DiabetesCompletedNCT00422487Phase 2
- Effect of Urtica Dioica on Glycemic Control in Patients With Type 2 Diabetes MellitusCompletedNCT00422357Phase 1
- Using Networks, Informatics, Technology, and Education in Care for People With DiabetesCompletedNCT00421850Not applicable
- Effect of Enalapril and Losartan Association Therapy on Proteinuria and Inflammatory Biomarkers in Diabetic Nephropathy: a Clinical Trial on Type 2 Diabetes MellitusCompletedNCT00419835Phase 4
- Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 DiabetesCompletedNCT00419718Phase 1
- To Compare the Effect of Inhaled Insulin With Subcutaneously Injected Insulin in Subjects With Type 2 Diabetes Mellitus.CompletedNCT00419302Phase 2
- Additional Glucose Lowering and Anti-Inflammatory Effects by Acarbose and Alcohol in Subjects With Impaired Glucose Tolerance or Mild Type 2 DiabetesStatus unknownNCT00417950Not applicable
- Eye on Diabetes: A Multidisciplinary Patient Education InterventionCompletedNCT00417924Early Phase 1
- Effects of Acarbose Versus Glibenclamide on MAGE and Oxidative Stress in Patients With Type 2 DMCompletedNCT00417729Phase 4
- Lifestyle Modification for Obesity-Related Type 2 DiabetesCompletedNCT00415688Phase 4
- Metformin for the Treatment of Diabetes in PregnancyStatus unknownNCT00414245Phase 3
- PACE-iDP: An Intervention for Youth at Risk for DiabetesCompletedNCT00412165Not applicable
- Clinical and Angiographic Outcomes With Hyperglycemic Control Post PCICompletedNCT00412126Not applicable
- Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 DiabetesTerminatedNCT00411892Phase 3
- Effect of Nuts vs. a Wheat Bran Muffin in Type 2 DiabetesStatus unknownNCT00410722Phase 2
- Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human InsulinCompletedNCT00410033Not applicable
- Intensive Medical Treatment for Nephropathy Caused by Type 2 Diabetes With HypertensionStatus unknownNCT00407680Phase 4
- Effects of Tinzaparin on Cardio-vascular Outcomes and on Blood Lipids in Diabetic Patients on Chronic HemodialysisWithdrawnNCT00407641Phase 4
- Retinal Blood Flow and Microthrombi in Type 1 DiabetesCompletedNCT00406991Phase 2
- Clinical Trial of SB-509 in Subjects With Diabetic NeuropathyCompletedNCT00406458Phase 2
- Oxidative Stress Lowering Effect of Simvastatin and Atorvastatin.Status unknownNCT00404599Phase 4
- Patient and Provider Attitudes in the Healthcare ContextCompletedNCT00404027
- Internet Intervention to Improve Rural Diabetes CareCompletedNCT00403091Not applicable
- Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or RosiglitazoneCompletedNCT00402909Phase 4
- "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DMCompletedNCT00402012Phase 4
- OatMeal and Insulin Resistance: OMA-IRCompletedNCT00401453Phase 3
- Vitamin D Supplementation to Patients With Type 2 DiabetesCompletedNCT00400491Phase 2
- A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 DiabetesCompletedNCT00400283Phase 1
- A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes MellitusCompletedNCT00399724Phase 4
- Effect of Repaglinide and Metformin Combination Tablet or Rosiglitazone and Metformin in Fixed Dose Combination on Blood Glucose Control in Patients With Type 2 DiabetesCompletedNCT00399711Phase 3
- Prevalence of Type 2 Diabetes Mellitus in Ethiopian Community in Israel: an UpdateCompletedNCT00399347
- Comparison of Cardiovascular Outcomes of Pioglitazone and Metformin in Type 2 Diabetes PatientsWithdrawnNCT00399204Phase 4
- Impact of a Computerized Guidelines on the Management of Hypertension and DiabetesCompletedNCT00398944Not applicable
- The Effects of Lipoic Acid on Glycaemic Control in Type 2 DiabetesWithdrawnNCT00398892Phase 2
- GOAL Life-Style Change Intervention to Prevent Type 2 DiabetesCompletedNCT00398060Phase 3
- Insulin Glulisine, Diabetes Mellitus Type 1CompletedNCT00397553Phase 3
- Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin AloneCompletedNCT00396357Phase 3
- Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin AloneCompletedNCT00396227Phase 3
- Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With MetforminCompletedNCT00396071Phase 3
- Vytorin Treating Uncontrolled Lipids (VyTUL) Study (0653A-122)TerminatedNCT00395603Phase 3
- The Diabetes Specialist Nurse as Delegated Main Care Provider for Patients With Type 2 DiabetesCompletedNCT00394875Not applicable
- Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 DiabetesCompletedNCT00394407Phase 4
- Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy VolunteersCompletedNCT00394030Phase 1
- Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes MellitusCompletedNCT00391209Phase 3
- SGS: a Structured Treatment and Teaching Programme for Elderly Patients With Diabetes MellitusCompletedNCT00391040Not applicable
- Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial)CompletedNCT00390728Phase 4
- Efficacy and Safety of Vildagliptin Versus Placebo in Patients With Type 2 DiabetesCompletedNCT00390520Phase 3
- Effect of an Extract of Green Tea on Adults With Type 2 DiabetesCompletedNCT00389350Phase 2/3
- A Drug-Drug Interaction Study of GK Activator (2) and Glyburide in Patients With Type 2 Diabetes.CompletedNCT00388986Phase 1
- A Study of Aleglitazar in Patients With Type 2 DiabetesCompletedNCT00388518Phase 2
- Diabetes Medication ChoiceCompletedNCT00388050Not applicable
- Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)WithdrawnNCT00387972Phase 2/3
- Automated Diabetes Prevention ProgramCompletedNCT00384488Not applicable
- Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 DiabetesCompletedNCT00383877Phase 3
- Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 DiabetesCompletedNCT00383578Phase 3
- Mitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During ExerciseTerminatedNCT00382473Not applicable
- A Study to Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 DiabetesCompletedNCT00382239Phase 2
- Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 DiabetesCompletedNCT00382096Phase 3
- Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992
- Effect of Vildagliptin on Fat and Muscle Metabolism in Patients With Type 2 DiabetesCompletedNCT00380445Phase 3
- A Study to Assess the Acute Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes.CompletedNCT00380380Phase 3
- A Drug-Drug Interaction Study of GK Activator (2) and Simvastatin in Patients With Type 2 Diabetes.CompletedNCT00377442Phase 1
- Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part IICompletedNCT00377117
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3
- Drug Interactions From Simultaneous Administration Of Metformin And GSK189075 To Subjects With Type 2 DiabetesCompletedNCT00376038Phase 1
- The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled TrialCompletedNCT00375388Phase 3
- Preventing Depression Recurrence in DiabetesCompletedNCT00374426Phase 4
- Improving Blood Pressure Management in Patients With DiabetesCompletedNCT00374270Phase 4
- Metabolic Effects of Treatment in Patients With Recently Diagnosed Type 2 DiabetesCompletedNCT00373178Phase 4
- Internet Diabetes Self-ManagementCompletedNCT00372463Phase 2
- The Effect of Cinnamon on HbA1c Among Adolescents With Type I DiabetesCompletedNCT00371800Phase 2/3
- Comparison of Glucovance to Insulin for Diabetes During PregnancyStatus unknownNCT00371306Not applicable
- MK-0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus (0431-043)CompletedNCT00371007Phase 2
- GW823093C For The Treatment Of Type 2 Diabetes MellitusTerminatedNCT00370942Phase 2
- Effect on Glycemic Control of Inhaled Insulin Alone or Added to Dual Oral Therapy After Failure of Dual Oral Therapy.CompletedNCT00370565Phase 3
- YUKON Choice Versus TAXUS Liberté in Diabetes MellitusCompletedNCT00368953Phase 4
- Dose-Exposure-Response in Type 1 Diabetes MellitusCompletedNCT00368394Phase 1
- A Study of the Effect of Renal Impairment on the Activity of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00368368Phase 1
- To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 DiabetesCompletedNCT00368134Phase 3
- A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and LantusCompletedNCT00367445Phase 4
- A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.CompletedNCT00366379Phase 2
- Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 DiabetesCompletedNCT00365170Phase 4
- Lifestyle Interventions for Long Term Diabetes ControlStatus unknownNCT00364312Not applicable